Özlem Demirelce

Özlem Demirelce

Auto-generated profile, based on publicly available information

Özlem Demirelce

Biochemistry Department Göztepe Prof Dr Süleyman Yalçın City Hospital İstanbul Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MKMeltem Kilercik
Meltem Kilercik
ÖDÖzlem Demirelce
Özlem Demirelce
MSMuhittin Abdulkadir Serdar
Muhittin Abdulkadir Serdar
PMParvana Mikailova
Parvana Mikailova
MSMustafa Serteser
Mustafa Serteser
Introduction: Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 virus, is a major public health concern spanning from healthy carriers to patients with life-threatening conditions. Although most of COVID-19 patients have mild-to-moderate clinical symptoms, some patients have severe pneumonia leading to death. Therefore, the early prediction of disease prognosis and severity is crucial in COVID-19 patients. The main objective of this study is to evaluate the haemocytometric parameters and identify severity score associated with SARS-CoV-2 infection. Methods: Clinical and laboratory records were retrospectively reviewed from 97 cases of COVID-19 admitted to hospitals in Istanbul, Turkey. The patient groups were subdivided into three major groups: Group 1 (Non-critical): 59 patients, Group 2 (Critical-Survivors): 23 patients and Group 3 (Critical-Non-survivors):15 patients. These data was tested for correlation, including with derived haemocytometric parameters. The blood analyses were performed the Sysmex XN-series automated hematology analyser using standard laboratory protocols. All statistical testing was undertaken using Analyse-it software. Results: 97 patients with COVID-19 disease and 935 sequential complete blood count (CBC-Diff) measurements (days 0–30) were included in the final analyses. Multivariate analysis demonstrated that red cell distribution width (RDW) (>13.7), neutrophil to lymphocyte ratio (NLR) (4.4), Hemoglobin (Hgb) (<11.4 gr/dL) and monocyte to neutrophil ratio (MNR) (0.084) had the highest area under curve (AUC) values, respectively in discrimination critical patients than non-critical patients. In determining Group 3, MNR (5.2), Plateletcount (PLT) (>142 x103/L) and RDW (>14) were important haemocytometric parameters, and the mortality risk value created by their combination had the highest AUC value (AUC = 0.911, 95% CI, 0886–0.931). Trend analysis of CBC-Diff parameters over 30 days of hospitalization, NLR on day 2, MNR on day 4, RDW on day 6 and PLT on day 7 of admission were found to be the best time related parameters in discrimination non-critical (mild-moderate) patient group from critical (severe and non-survivor) patient group. Conclusion: NLR is a strong predictor for the prognosis for severe COVID-19 patients when the cut-off chosen was 4.4, the combined mortality risk factor COVID-19 disease generated from RDW-CV, NLR, MNR and PLT is best as a mortality haematocytometric index.

26 May 2020 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
ÖDÖzlem Demirelce
Özlem Demirelce
FAFehime Benli Aksungar
Fehime Benli Aksungar
NSNeslihan Yildirim Saral
Neslihan Yildirim Saral
MKMeltem Kilercik
Meltem Kilercik
MSMustafa Serteser
Mustafa Serteser
IUIbrahim Unsal
Ibrahim Unsal
Background: The tandem mass spectrometry method in the screening of congenital metabolic disorders is not included in routine national newborn screening programmes in Turkey. To evaluate the distribution of acylcarnitines and amino acid levels in normal newborns, establish acylcarnitine and amino acid cut-off levels and further preliminary results of inherited metabolic disorders inferentially in the Turkish population. Methods: Newborn screening tests performed by tandem MS from 2016 to 2018 were retrospectively reviewed. The study group included 17,066 newborns born in our hospitals located in various regions of Turkey. Blood samples were obtained from infants older than 24 h of age. Among the 17,066 newborns, the metabolic screening data of 9,994 full-term newborns (>37 weeks) were employed to obtain the percentile distribution of the normal population. The study group (17,066) was screened for 26 types of inborn error of metabolism. Results: Our established cut-offs, were compared with the cut-offs determined by Region for Stork Study and Centers for Disease Control. Among the 26 screened disorders, a total of 12 cases (8 amino acid metabolism disorders, 1 urea cycle defect, 2 organic acidaemias and 1 fatty acid oxidation disorder) were identified. Conclusions: Because of the high rate of consanguineous marriages in Turkey, the development of a nationwide screening panel is necessary for early detection and management of potentially treatable inherited metabolic disorders.

10 May 2023 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
EOEsra Ozbasli
Esra Ozbasli
OTOzguc Takmaz
Ozguc Takmaz
GUGozde Unsal
Gozde Unsal
EKEbru Kazancı
Ebru Kazancı
ODOzlem Demirelce
Ozlem Demirelce
MGMete Gungor
Mete Gungor

8 December 2025 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
ODOzlem Demirelce
Ozlem Demirelce
BIBerrin Bercik Inal
Berrin Bercik Inal
ACAbdurrahman COSKUN
Abdurrahman COSKUN

20 March 2026 in Journal of Clinical and Analytical Medicine
Verified
Journal Article
Closed access
ÖDÖzlem Demirelce
Özlem Demirelce

9 September 2026 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
ACAbdurrahman COSKUN
Abdurrahman COSKUN
ÖDÖzlem Demirelce
Özlem Demirelce